Acute Oncology Guidelines for Non Cancer Specialists
These Clinical Guidelines provide a description of the range of treatment options available for a clinical scenario. Treatment decisions for individual patients requires consideration of a multitude of factors, which cannot all be accounted for in a clinical guideline.
This guidance has been produced to support the diagnosis and treatment of acute oncological complications:
- NICaN Acute Oncology Guidelines Jan 22 March 25 Jan 26
- NICaN Acute Oncology Clinical Guideline Chemotherapy Extravasation Drug Management Procedures
- NICaN Checkpoint Inhibitor Immunotherapy Toxicity Management Guidelines May 25 to support the management of immune-related adverse events for patients receiving immunotherapy
- Guidence For Management Of Patients Who Become ill During And Within 6 Weeks Of Receiving Radiotherapy At NICC 2025
The latest NICaN Acute Oncology Clinical Guidelines and Immunotherapy Toxicity Guideline are available on the Eolas Medical APP.
